Lisocabtagene Maraleucel,ibrutinib,venetoclax
Bms,Roche,Abbvie,janssen
['liso-cel', 'transcend,(-nhl-001),(-nhl 001),(-nhl001),(-nhl-006),(-nhl 006),(-nhl006),(-pilot-017006),(-pilot017006),(-pilot 017006)', 'cll']
transcend cll at #icml17 by dr. siddiqi
cr rate 18% among liso-cel recipients with double-ref cll, -&gt; long dor
blood umrd 63%
85% crs, 45% neurotox, 54% prolonged cytopenias need strategies to improve cart efficacy in cll &amp; mitigate tox 
Professor & Co-Director, Toni Stephenson Lymphoma Center #CLL #lymphoma, translational researcher (molecular therapeutics, IO) @cityofhope. Views my own